TrialLineage Concept

UBE3A

UBE3A encodes an E3 ubiquitin ligase that plays a critical role in neuronal function and development. In most of the body, both parental copies of UBE3A are expressed. In neurons, only the maternal copy is active due to genomic imprinting — making loss of the maternal allele the direct cause of Angelman syndrome.

In plain language

What does UBE3A do?

UBE3A (ubiquitin protein ligase E3A) tags specific proteins with ubiquitin, marking them for degradation by the cell’s waste disposal system (the proteasome). In neurons, this protein quality control is essential for synaptic function, plasticity, and normal brain development.

The gene is located on chromosome 15q11.2-q13, within a region subject to complex genomic imprinting. In neurons — and apparently only in neurons — a long antisense RNA transcript (UBE3A-ATS) originating from the SNURF-SNRPN locus traverses the UBE3A gene and silences the paternal allele. This means neurons depend entirely on the maternal UBE3A copy.

Why UBE3A matters for therapy

The imprinting pattern of UBE3A creates both the disease and the therapeutic opportunity. Because the paternal allele is silenced rather than absent, it represents a dormant source of functional protein. If the silencing mechanism (UBE3A-ATS) can be reduced, the paternal allele might resume expression — effectively compensating for the lost maternal copy.

This “unsilencing” strategy is the basis for ION582 and other investigational Angelman therapies. It depends on three facts: the paternal gene is intact, the silencing mechanism is RNA-mediated, and ASOs can target that RNA.

Position in the scientific lineage

UBE3A sits at the intersection of ubiquitin biology, genomic imprinting, neurodevelopment, and RNA regulation. Its identification as the Angelman gene (1997) was a pivotal step, but the therapeutic path required additional discoveries: characterization of the antisense transcript, demonstration of ASO-mediated unsilencing in models, and proof that intrathecal delivery could reach affected neurons.

Related concepts

Angelman syndromeGene expressionRNA biologyAntisense oligonucleotides